approval
saveNALBUPHINE HYDROCHLORIDE — FDA approval
community read0 votes
Sponsor: HOSPIRA. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 282d ago
same company · ±60 days · 6
- approvalBUTORPHANOL TARTRATE: BUTORPHANOL TARTRATE PRESERVATIVE FREE (BUTORPHANOL TARTRATE) — FDA approvalOct 25, 2002
- approvalEffentora: FENTANYL CITRATE — FDA approvalOct 25, 2002
- approvalLaryng-O-Jet: LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% (LIDOCAINE HYDROCHLORIDE) — FDA approvalOct 25, 2002
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalOct 25, 2002
- approvalEffentora: FENTANYL CITRATE — FDA approvalOct 7, 2002
- approvalBUTORPHANOL TARTRATE: BUTORPHANOL TARTRATE PRESERVATIVE FREE (BUTORPHANOL TARTRATE) — FDA approvalSep 18, 2002
comments(0)
5-min edit window · permanent after that